Pall Corporation Launches Three New Allegro™ Connect Systems

Pall Corporation extends its bioprocessing solution portfolio with the launch of three new Allegro Connect Systems. In conjunction with Pall’s Allegr...

 September 28, 2022 | News

Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor

NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the...

 September 27, 2022 | News

IQVIA Market Reflection Report pins JB Pharma as the fastest growing Pharma Company with a growth rate of over 20% for the month of August 2022

JB Pharma is sitting pretty, ranked at a healthy 23 among the Indian Pharmaceutical players and underlining its meteoric rise with an outstanding growth ra...

 September 22, 2022 | News

ClavystBio launches to translate life sciences breakthroughs into health impact

ClavystBio, a company established by CLA Real Estate Holdings, a wholly-owned subsidiary of Temasek, today announced its launch to accelerate the commercia...

 September 15, 2022 | News

Cytiva launches BioChallenge in Southeast Asia to support biotech startup development

BioChallenge facilitates access to Cytiva's services and expertise to scale up efficiently, mitigate risks and reduce time to go to market Application p...

 September 12, 2022 | News

Merck strengthens its manufacturing capabilities for single-use assemblies by investing more than € 130 million in Molsheim, France.

Increases manufacturing capacity for the Mobius® single-use portfolio Creates more than 800 jobs by the end of 2028 Investment further strengt...

 September 12, 2022 | News

Juniper Biologics signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East

Giorgio Calderari, Helsinn CEO commented: "I am pleased to announce this agreement with Juniper Biologics today which further widens the geographic di...

 September 02, 2022 | News

Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator

This academic and industry relationship will establish independent cell and gene therapy companies to advance the development of Mayo Clinic technologies t...

 September 01, 2022 | News

Biocytogen Expands Partnership with Merck

Under the terms of the agreement, Merck will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibo...

 August 29, 2022 | News

Forecyte Bio and Cytiva team up to accelerate development and manufacturing of cell and gene therapies

Cytiva, a global life sciences leader, and ForecyteBio, a cell and gene therapy (CGT) contract development and manufacturing organization (CDMO), are ...

 August 25, 2022 | News

Thermo Fisher Scientific Expands Viral Vector Manufacturing Capabilities

Thermo Fisher Scientific, the world leader in serving science, today expanded its cell and gene therapy capabilities with the opening of its new previ...

 August 24, 2022 | News

Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapi...

 August 23, 2022 | News

Merck to Acquire Chemical Business of Mecaro

Acquisition supports “Level Up” growth ambition of Merck’s Electronics business to further expand its regional capabilities and global ...

 August 18, 2022 | News

Agilent Reports Third-Quarter Fiscal Year 2022 Financial Results

Highlights: Revenue of $1.72 billion represents 8% reported growth year-over-year; and up 13% on a core(1) basis. GAAP net income of $329 million ...

 August 17, 2022 | News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in